Roflumilast Tablet
FDA Label NDC 70771-1674

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Roflumilast (NDC 70771-1674). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1674-3

Roflumilast Tablets, 500 mcg

30 tablets

Rx only

500 Mcg Label (Eb40db9e Ddc1 4041 Aac5 Ff0f2c478fc6 01)

500 Mcg Label (Eb40db9e Ddc1 4041 Aac5 Ff0f2c478fc6 01)

NDC 70771-1673-8

Roflumilast Tablets, 250 mcg

Blister pack of 28 tablets

Rx only

250 Mcg Blister Label (Eb40db9e Ddc1 4041 Aac5 Ff0f2c478fc6 02)

250 Mcg Blister Label (Eb40db9e Ddc1 4041 Aac5 Ff0f2c478fc6 02)

* Please review the disclaimer below.